Biotech Leader to Provide Longevity Insights at Annual Conference Ramsey, Isle of Man – November 1, 2022 – Juvenescence Limited (“Juvenescence”), a life sciences company developing therapies and consumer products...
Developing Modalities to Influence Longevity and Health
with a deep focus on prevention
We've Got the Aging Market Covered
Using an integrated hybrid model, we cover the entire aging market with a portfolio ranging from pharmaceuticals and nutritional therapies to regeneration.
Latest News and Publications
AgeX Therapeutics announces a manufacturing, marketing and distribution agreement with Pluristyx, an advanced therapy tools and services company, to expand access to clinical-grade human pluripotent stem cells for therapeutic applications.
LyGenesis announces four new peer-reviewed publications highlighting its advancing technology for kidney and liver regeneration.
In the News
It sounds like science fiction: people with end-stage liver disease are injected with cells from a donor liver and, in response, their body produces multiple mini livers that keep them healthy. Yet,...
Jim Mellon, Juvenescence Chairman, explains why investing in longevity has the potential to deliver significant financial, personal and humanitarian returns. “There’s a lot of great stuff happening, but it’s not...
A series of upcoming studies will explore whether the grind of active-duty military life and veterans’ disproportionately high incidence of chronic illness could be tamed by lifestyle interventions designed to...